Published in Phys Rev Lett on February 18, 2010
Template engineering of Co-doped BaFe2As2 single-crystal thin films. Nat Mater (2010) 2.22
Artificially engineered superlattices of pnictide superconductors. Nat Mater (2013) 1.18
In-situ growth of superconducting SmO1-xFxFeAs thin films by pulsed laser deposition. Sci Rep (2016) 0.78
Secretion of plasminogen activator by stimulated macrophages. J Exp Med (1974) 8.82
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. I. Chick embryo fibroblast cultures transformed by avian RNA tumor viruses. J Exp Med (1973) 5.53
Actinomycin and nucleic acid function. Prog Nucleic Acid Res Mol Biol (1964) 5.00
An enzymatic function associated with transformation of fibroblasts by oncogenic viruses. II. Mammalian fibroblast cultures transformed by DNA and RNA tumor viruses. J Exp Med (1973) 4.99
P-TEFb kinase recruitment and function at heat shock loci. Genes Dev (2000) 4.07
A study of proteases and protease-inhibitor complexes in biological fluids. J Exp Med (1978) 3.92
High-resolution localization of Drosophila Spt5 and Spt6 at heat shock genes in vivo: roles in promoter proximal pausing and transcription elongation. Genes Dev (2000) 3.79
Base specificity in the interaction of polynucleotides with antibiotic drugs. Science (1965) 3.72
Fluorescence studies of nucleotides and polynucleotides. I. Formycin, 2-aminopurine riboside, 2,6-diaminopurine riboside, and their derivatives. J Biol Chem (1969) 3.39
The human tissue plasminogen activator gene. J Biol Chem (1986) 3.35
Fibrinolysis associated with oncogenic transformation. Requirement of plasminogen for correlated changes in cellular morphology, colony formation in agar, and cell migration. J Exp Med (1973) 3.16
On the validity of the Beck Depression Inventory. A review. Psychopathology (1998) 3.16
Macrophage plasminogen activator: modulation of enzyme production by anti-inflammatory steroids, mitotic inhibitors, and cyclic nucleotides. Cell (1976) 3.13
Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab plus irinotecan. J Neurooncol (2008) 2.97
Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator. J Biol Chem (1974) 2.89
Plasminogen activator in early embryogenesis: enzyme production by trophoblast and parietal endoderm. Cell (1976) 2.87
Antibodies to plasminogen activator inhibit human tumor metastasis. Cell (1983) 2.82
Replication and inheritance of mitochondrial DNA. Proc Natl Acad Sci U S A (1966) 2.72
Pneumococcal polysaccharide immunization in infants and children. Pediatrics (1978) 2.67
Secretion of plasminogen activator by human polymorphonuclear leukocytes. Modulation by glucocorticoids and other effectors. J Exp Med (1977) 2.60
Improving depression outcomes in community primary care practice: a randomized trial of the quEST intervention. Quality Enhancement by Strategic Teaming. J Gen Intern Med (2001) 2.56
Macrophage plasminogen activator: induction by concanavalin A and phorbol myristate acetate. Cell (1977) 2.47
Incisional hernia rate 3 years after midline laparotomy. Br J Surg (2013) 2.37
Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut (2008) 2.36
Psychiatric sequelae of posttraumatic stress disorder in women. Arch Gen Psychiatry (1997) 2.29
Hyaluronidase induction of a WW domain-containing oxidoreductase that enhances tumor necrosis factor cytotoxicity. J Biol Chem (2000) 2.20
Cloning, nucleotide sequencing and expression of cDNAs encoding mouse urokinase-type plasminogen activator. Eur J Biochem (1985) 2.14
Mammary plasminogen activator: correlation with involution, hormonal modulation and comparison between normal and neoplastic tissue. Cell (1979) 2.13
Mediator, not holoenzyme, is directly recruited to the heat shock promoter by HSF upon heat shock. Mol Cell (2001) 2.00
Macrophage plasminogen activator: induction by products of activated lymphoid cells. J Exp Med (1977) 2.00
A proenzyme form of human urokinase. J Biol Chem (1982) 1.98
Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala. Ann Neurol (1992) 1.95
Effects of propranolol in non-Q-wave acute myocardial infarction in the beta blocker heart attack trial. Am J Cardiol (1990) 1.94
Ovarian plasminogen activator: relationship to ovulation and hormonal regulation. Cell (1975) 1.93
Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat. Brain Res Dev Brain Res (1991) 1.90
Properties of plasminogen activators formed by neoplastic human cell cultures. J Exp Med (1974) 1.88
Spread of a Salmonella typhimurium clone resistant to expanded-spectrum cephalosporins in three European countries. J Clin Microbiol (1999) 1.79
Isolation and characterization of Clostridium botulinum type B toxin. J Biol Chem (1969) 1.79
Hormonal regulation of plasminogen activator mRNA production in porcine kidney cells. Cell (1983) 1.76
Sex differences in depression: a role for preexisting anxiety. Psychiatry Res (1995) 1.76
The acetylcholine receptor. I. Purification and characterization of a macromolecule isolated from Electrophorus electricus. J Biol Chem (1973) 1.75
Structure and activity of acetylcholine. Nature (1970) 1.75
Role of serum carbohydrate antigen 19-9 and carcinoembryonic antigen in distinguishing between benign and invasive intraductal papillary mucinous neoplasm of the pancreas. Br J Surg (2010) 1.73
Gastric emptying, glucose responses, and insulin secretion after a liquid test meal: effects of exogenous glucagon-like peptide-1 (GLP-1)-(7-36) amide in type 2 (noninsulin-dependent) diabetic patients. J Clin Endocrinol Metab (1996) 1.70
Pilot trial of IOM duty hour recommendations in neurology residency programs: unintended consequences. Neurology (2011) 1.69
The interaction of actinomycin with DNA: requirement for the 2-amino group of purines. Proc Natl Acad Sci U S A (1967) 1.65
Prospective study of manikin-only versus manikin and human subject endotracheal intubation training of paramedics. Ann Emerg Med (1991) 1.63
Clinical performance of a laser fluorescence device for detection of occlusal caries lesions. Eur J Oral Sci (2001) 1.62
Performance and reproducibility of a laser fluorescence system for detection of occlusal caries in vitro. Caries Res (1999) 1.62
Adaptive modulations of martensites. Phys Rev Lett (2010) 1.62
The electronic phase diagram of the LaO(1-x)F(x)FeAs superconductor. Nat Mater (2009) 1.60
Placebo-controlled phase I/II studies of minocycline in amyotrophic lateral sclerosis. Neurology (2004) 1.60
Febrile seizures: an appropriate-aged model suitable for long-term studies. Brain Res Dev Brain Res (1997) 1.60
Macrophage plasminogen activator: induction by asbestos is blocked by anti-inflammatory steroids. J Exp Med (1976) 1.60
Interstitial trypsinogen release and its relevance to the transformation of mild into necrotizing pancreatitis in rats. Gastroenterology (1999) 1.60
Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice. J Exp Med (1978) 1.60
Clinical significance of liver ischaemia after pancreatic resection. Br J Surg (2011) 1.59
Education research: Bias and poor interrater reliability in evaluating the neurology clinical skills examination. Neurology (2009) 1.58
Purification of murine T cell growth factor. A lymphocyte mitogen with helper activity. J Exp Med (1981) 1.57
A specific labeling procedure for proteins on the outer surface of membranes. J Biol Chem (1972) 1.55
Prevalence of activating K-ras mutations in the evolutionary stages of neoplasia in intraductal papillary mucinous tumors of the pancreas. Ann Surg (1997) 1.55
Triflusal vs aspirin for prevention of cerebral infarction: a randomized stroke study. Neurology (2004) 1.52
[S3-Guidelines "Exocrine pancreatic cancer" 2007]. Z Gastroenterol (2007) 1.52
Fracture mechanisms in bulk metallic glassy materials. Phys Rev Lett (2003) 1.52
Development of an integrated laboratory information management system for the maize mapping project. Bioinformatics (2003) 1.50
Fibrinolysis associated with oncogenic transformation. Morphological correlates. J Biol Chem (1974) 1.50
Phospholipid composition of Rous sarcoma virus, host cell membranes and other enveloped RNA viruses. Virology (1971) 1.49
Propofol sedation for colonoscopy with a new ultrathin or a standard endoscope: a prospective randomized controlled study. Endoscopy (2013) 1.48
Isolation and characterization of urokinase from human plasma. J Biol Chem (1982) 1.47
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs. Proc Natl Acad Sci U S A (1999) 1.46
Ammonium ions as the source of nitrogen for tryptophan biosynthesis in whole cells of Escherichia coli. Biochim Biophys Acta (1967) 1.46
Experimental aspects of peripheral vascular occlusion of the intestine. Surg Gynecol Obstet (1965) 1.45
Desmopressin impairs microcirculation in donor pancreas and early graft function after experimental pancreas transplantation. Transplantation (2001) 1.44
cDNA and gene nucleotide sequence of porcine plasminogen activator. Nucleic Acids Res (1984) 1.43
The presence of Herpesvirus Saimiri genomes in virus-transformed cells. Int J Cancer (1977) 1.43
Plasminogen, the serum proenzyme activated by factors from cells transformed by oncogenic viruses. J Biol Chem (1974) 1.43
Corticotropin-releasing hormone (CRH)-containing neurons in the immature rat hippocampal formation: light and electron microscopic features and colocalization with glutamate decarboxylase and parvalbumin. Hippocampus (1998) 1.42
Antisense transcription: a critical look in both directions. Cell Mol Life Sci (2009) 1.42
Gene expression and cAMP. Proc Natl Acad Sci U S A (1985) 1.41
Preoperative tissue diagnosis for tumours of the pancreas. Br J Surg (2009) 1.39
[The pre-positioned intracutaneous suture--a method for treatment of soft tissue defects after fascia splitting in acute compartment syndrome]. Chirurg (1994) 1.39
Filopodia formation induced by active mDia2/Drf3. J Microsc (2008) 1.39
An improved assay for interleukin 2 (lymphocyte growth factor) produced by mitogen-activated lymphocytes. Aust J Exp Biol Med Sci (1980) 1.38
Acro-renal-ocular syndrome: expansion of the phenotype. Clin Dysmorphol (1998) 1.38
Recombinant human erythropoietin for the treatment of the anaemia associated with autologous bone marrow transplantation. Br J Haematol (1994) 1.38
Effects of subcutaneous glucagon-like peptide 1 (GLP-1 [7-36 amide]) in patients with NIDDM. Diabetologia (1996) 1.37
Spatial distribution of vital and dead microorganisms in dental biofilms. Arch Oral Biol (2001) 1.34
Experimental model for quantitative study of metastasis. Cancer Res (1980) 1.32
Exonuclease VI, a new nuclease activity associated with E. coli DNA polymerase. Proc Natl Acad Sci U S A (1968) 1.32
Changes in malignant phenotype of a human carcinoma conditioned by growth environment. Cell (1983) 1.31
Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma. J Clin Oncol (2001) 1.31
Oral hydralazine therapy for chronic refractory heart failure. Circulation (1976) 1.30
RNA and protein synthesis in human peripheral blood polymorphonuclear leukocytes. J Exp Med (1979) 1.30
Abnormal corticosterone regulation in an immature rat model of continuous chronic stress. Pediatr Neurol (1996) 1.30
Sugars and flowering in the grapevine (Vitis vinifera L.). J Exp Bot (2008) 1.30
Selective lysis of cells transformed by Rous Sarcoma virus. Virology (1971) 1.29
Acetylcholine receptor. Responses to drug binding. J Biol Chem (1977) 1.29
SEPARATION OF THE BIOSYNTHESIS OF THE ANTIBIOTIC POLYPEPTIDE TYROCIDINE FROM PROTEIN BIOSYNTHESIS. Proc Natl Acad Sci U S A (1963) 1.28
Effect of antifungal agents on lipid biosynthesis and membrane integrity in Candida albicans. Antimicrob Agents Chemother (1987) 1.26